Related Experiment Video
Updated: May 1, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
[Topical glycopyrronium bromide as a cause of pupillary changes]
Marie Kirstine Hjorth1, Anne Kragh Hansen2, Agnes Galbro Brost3
1Dermato-Venerologisk Afdeling, Københavns Universitetshospital - Bispebjerg Hospital.
Abstract:
Topical glycopyrronium bromide is an acetylcholine receptor antagonist approved for the treatment of severe primary axillary hyperhidrosis in adults. The ointment is often prescribed off-label for hyperhidrosis on palms and soles. This case report presents ocular side effects after topical glycopyrronium bromide use, leading to several clinical follow-ups and diagnostic tests. This case report underscores the importance of recognising potential side effects for clinicians, especially in off-label treatment.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Cholinergic Antagonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Angle Closure Glaucoma: Treatment

